FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to compounds of general formula (I-B), 
where values of radicals are described in formula of invention, or to its pharmaceutically acceptable salts, which possess activity of inhibiting cholesterol ester transfer protein, due to which said compounds or salts can be used for prevention and/or treatment of arteriosclerotic diseases, hyperlipemia or dislipidemia or similar diseases.
EFFECT: obtaining pharmaceutical compositions for prevention and treatment of arteriosclerosis, as well as application of formula I-B compounds for manufacturing of medication.
15 cl, 36 tbl, 252 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TETRAHYDRO-NAPHTHYRIDINE DERIVATIVES AND METHOD OF THEIR OBTAINING | 2005 |
|
RU2356902C2 |
| NEW PYRIDINE DERIVATIVE AND PYRIMIDINE DERIVATIVE (1) | 2005 |
|
RU2330021C2 |
| DERIVATIVES OF PIPERIDINE, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, THEIR USING AND TREATMENT METHOD | 2003 |
|
RU2294927C2 |
| AMINOPYRAZINE DERIVATIVES AND MEDICATIONS | 2010 |
|
RU2535217C2 |
| BICYCLIC HETEROCYCLIC AMINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AS INHIBITORS OF REACTIVE OXYGEN | 1993 |
|
RU2103272C1 |
| PYRAZOLE PYRIMIDINE DERIVATIVES AND USING THEM AS PDE10 INHIBITORS | 2011 |
|
RU2543386C2 |
| NITROGEN-CONTAINING AROMATIC DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR TREATMENT AND USING | 2003 |
|
RU2310651C2 |
| NON-NUCLEOSIDE REVERSE TRANCRIPTASE INHIBITORS, USES THEREOF, PHARMACEUTICAL COMPOSITION FOR HIV INHIBITION | 2004 |
|
RU2305680C2 |
| UREA COMPOUND THAT IS ANTAGONIST OF LPA1 RECEPTOR | 2020 |
|
RU2805922C2 |
| PYRIMIDINE SUBSTITUTED MACROCYCLIC HCV INHIBITORS | 2008 |
|
RU2481340C2 |
